What:
A combination of partnering and exhibition, ATW (or “Phacilitate” to the industry veterans) is an event that highlights the latest in cell and gene therapy business and market trends. This is not a technical forum but rather provides a broad overview of the CGT industry while affording good networking opportunities.
Who:
CGT developers; CGT tools and service providers; investors.
What:
A Japan-focused event for peptide and oligonucleotide-based therapeutics that still brings a global flavor. More recently, mRNA and gene- editing content has also been included. A scientific program including posters and oral presentations, with topics ranging from discovery to R&D to CMC and commercialization. A small but growing exhibition for peptide/oligo/mRNA tools and service providers reflects the emergence of oligos and mRNA in Japan and throughout Asia.
Who:
Peptide, oligo, and mRNA developers, suppliers, and service providers; engineering companies; academics.
What:
The so-called “largest event dedicated to peptide and oligonucleotide- based therapeutics,” TIDES USA is a renowned global event for oligos and peptides. More recently, mRNA and gene- editing content has also been included. A strong scientific program including posters and high-profile oral presentations, with topics ranging from discovery to R&D to CMC and commercialization. An impressive exhibition landscape for peptide/oligo/ mRNA tools and service providers. Highly recommended if you wish to learn about this space.
Who:
Peptide, oligo, and mRNA developers, suppliers, and service providers; engineering companies; academics.
What:
The largest and most comprehensive event for biotechnology, with over 20,000 participants from round the world. A massive exhibition with a very broad audience – much more business- oriented than technical. Expect business development and corporate types more than research scientists and process engineers – but good for networking in that regard.
Who:
Big pharma and small biotech searching for licensing partners or investment; suppliers and service providers promoting their capabilities; investors; legal/IP firms; other business service firms.
What:
Branded as “Asia’s Leading Pharma & Bio Tech Show,” INTERPHEX WEEK TOKYO is actually a compilation of several specialized shows under one roof at Tokyo’s Big Sight exhibition hall. Namesake show INTERPHEX JAPAN is the leading expo for pharmaceutical manufacturing, packaging and contract manufacturing. in-PHARMA JAPAN focuses on APIs, intermediates, and ingredients for pharmaceuticals and cosmetics. BioPharma EXPO is Japan’s largest show for biopharmaceutical R&D, manufacturing technology, CROs, and CDMOs. PharmaLab EXPO focuses on laboratory and drug discovery technology. Finally, at the Regenerative Medicine EXPO you will find the latest tools, technologies, products and services for regenerative medicine and tissue engineering. In total, over 900 exhibitors and over 34,000 visitors will attend. Keynotes and presentations are also showcased, with many of them bilingual to cater to the ever-increasing global audience.
Who:
Pharma, biopharma, and CGT developers, suppliers, and service providers; engineering companies; distributors; trading companies.
What:
One of the best, if not the best, partnering meeting for cell and gene therapies. Not an expo, and not a scientific symposium, Meeting on Mesa is primarily for business partnering in the CGT space. Topics include technical trends in CGT development, clinical trial design, manufacturing, supply chain, and reimbursement models for advanced therapies. If your needs include licensing partners, venture capital investment, marketing collaborations, or good old- fashioned networking in CGT, Mesa is the place to be.
Who:
CGT developers; global pharma; healthcare providers; investors; CGT tools and service providers.